Principal Investigator/Program Director (Last, First, Middle): BIOGRAPHICAL SKETCH Provide the following information for the key personnel and other significant contributors in the order listed on Form Page 2. Follow this format for each person. DO NOT EXCEED FOUR PAGES. NAME POSITION TITLE Janet M. Oliver Regents’ Professor and Harvey Chair of Pathology eRA COMMONS USER NAME joliver EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, and include postdoctoral training.) DEGREE INSTITUTION AND LOCATION (if YEAR(s) FIELD OF STUDY applicable) University of Adelaide, Australia B. Sc 1966 Biochemistry/Zoology Flinders University of South Australia B. Sc Hons 1967 Biochemistry University of Alberta, Edmonton, Canada M. Sc 1969 Biochemistry London University, London, UK Ph D 1972 Biochemistry Harvard Medical School, Boston, MA Post Doc 1973 Cell Physiology Personal Statement Dr. Oliver is Director of the Cell Pathology Division in the UNM Department of Pathology and Associate Director for Professional Development and Partnerships in the UNM Cancer Center. She is the co-Director of two Center grants for interdisciplinary research and training, the New Mexico Spatiotemporal Modeling Center (stmc.health.unm.edu) and the New Mexico Cancer Nanotechnology Training Center (cntc.unm.edu). The Centers are administered through the UNMCC and provide research support and training for faculty, postdoctoral fellows and graduate students working in the CC research programs. Positions 1973 - 1983 Assistant to Full Professor, Depts. of Physiology & Pathology, U. of Connecticut Health Center 1983 - Present Professor, Department of Pathology, University of New Mexico Health Sciences Center 1984 - 1990 Director, UNM/LANL Graduate Program in Cell and Molecular Biology and Biophysics 1987 - 1994 Director, The Center for Structural Biology, University of New Mexico School of Medicine 1990 - Present Associate Director for Research, UNM Cancer Research and Treatment Center 1992 - 2010 PI and Director, American Cancer Society Institutional Research Grant (ACS IRG) program 1996 - 2000 PI and Director, NIH/NCRR Institutional Development Award (IDeA) 2002 – 2012 PI and Director, NIH/NIGMS National Center for Systems Biology/New Mexico Center for the Spatiotemporal Modeling of Cell Signaling 2002-present Professor, Department of Biology, University of New Mexico 2010 – present Co-PI and Co-Director (with A. Datye), NCI Cancer Nanotechnology Training Center Honors 1972-1973 Leukemia Society of America Postdoctoral Fellowship 1977-1982 American Cancer Society Faculty Research Award 1993-1994 ACS Scholar Award 1996-Present UNM Regents’ Professor 2002 UNM SOM Excellence in Research and Leadership Award 2002-2004 Associate Editor, Journal of Immunology 2006 Distinguished Alumnus Award, Flinders University of South Australia 2010 Elected Fellow of the American Association for the Advancement of Science (AAAS) 2011 Appointed Frederick H. Harvey Chair of Pathology Fifteen Selected Publications (from more than 160) 1. Hutchcroft JE, Geahlen RL, Deanin GG and Oliver JM. FcRI-mediated tyrosine phosphorylation and activation of the 72 kDa protein-tyrosine kinase, PTK72/Syk, in RBL-2H3 rat tumor mast cells. Proc Natl Acad Sci 1992; 89: 9107-9111. 2. Ortega EM, Lara M, Lee I, Santana C, Martinez AM, Pfeiffer JR, Lee RJ, Wilson BS and Oliver JM. Lyn dissociation from phosphorylated FcRI subunits: a new regulatory step in the FcRI signaling cascade revealed by studies of FcRI dimer signaling activity. J Immunol 1999;162: 176-185. PHS 398/2590 (Rev. 11/07) Page Biographical Sketch Format Page Principal Investigator/Program Director (Last, First, Middle): 3. Wilson BS, Pfeiffer JR, Surviladze Z, Gaudet EA and Oliver JM. 2001. High resolution mapping of mast cell membranes reveals primary and secondary domains of FcRI and LAT. J Cell Biol 2001; 154: 645-658. 4. Youssef LA, Wilson BS and Oliver JM. Proteasome-dependent regulation of Syk tyrosine kinase expression in human basophils. J Allergy Clin Immunol 2002; 110: 366-373. 5. Wilson BS, Steinberg SL, Leiderman K, Pfeiffer JR, Surviladze Z, Zhang J, Samelson LE, Yang LH, Kotula PG, and Oliver JM. Markers for detergent-resistant lipid rafts occupy distinct and dynamic domains in native membranes. Mol Biol Cell 2004; 15: 2580-2592. 6. Frankel DJ, Pfeiffer JR, Oliver JM, Wilson BS and Burns AR. FcRI signaling domains observed as distinct topographic features on the inside of mast cell membranes. Biophys J 2006; 90: 2404–2413. 7. Torigoe C, Faeder JR, Oliver JM and Goldstein B. Kinetic proofreading of ligand-FcRI interactions persists beyond LAT phosphorylation. J Immunol 2007;178: 3530 - 3535. 8. Zhang, J, SL Steinberg, BS Wilson, JM Oliver and LR Williams. Markov random field modeling of the spatial distribution of proteins on cell membranes. Bull Math. Biol. 2008; 70: 297-321. 9. Andrews, NL, KA Lidke, JR. Pfeiffer, AR Burns, BS Wilson, JM Oliver, and DS Lidke. Actin restricts FcεRI diffusion and facilitates antigen-induced receptor immobilization. Nature Cell Biol. 2008; 10: 955-963. 10. Andrews, NL, JR Pfeiffer, AM Martinez, DM Haaland, RW Davis, T Kawakami, JM Oliver, BS Wilson and DS Lidke. Small, Mobile FcεRI Receptor Aggregates Are Signaling Competent. Immunity 2009:31:469–479. 11. Radhakrishnan, K, J Edwards, D Lidke, T Jovin, B Wilson, and J Oliver. Sensitivity Analysis Predicts that the ERK-pMEK Interaction Regulates ERK Nuclear Translocation. IET Systems Biology 3: 329-341 2009. 12. Carroll-Portillo, A, K Spendier, J Pfeiffer, G Griffiths, H Li, JM Oliver, D Lidke, J Thomas, BS Wilson and J Timlin. FcεRI Membrane Dynamics upon Binding Mobile or Immobile Ligands on Surfaces: Formation of a Mast Cell Synapse. J Immunol. 2010: 184:1328-38. 13. Wilson, BS, J.M. Oliver, D.S. Lidke. Spatiotemporal signaling in mast cells. In: Mast Cell Biology, Contemporary and Emerging Topics, Editors, Dean Metcalfe and Alasdair Gilfillan. Landes BioScience and Springer Science. 2011; 716: 91-106. 14. Espinoza, FA, JM Oliver, BS Wilson, SL Steinberg. Using Hierarchical Clustering and Dendrograms to Quantify the Clustering of Membrane Proteins. Bull. Math. Biol. 2012:74; 190-211. 15. Espinoza, FA, MJ Wester, JM Oliver, BS Wilson, NL Andrews, DS Lidke and SL Steinberg. Insights Into Cell Membrane Microdomain Organization from Live Cell Single Particle Tracking of the IgE High Affinity Receptor FcεRI of Mast Cells. Bull. Math. Biol. 2012: 74; 1857-1911. Research Support NIH P50GM085273 (Wilson, Oliver) 8/1/09-7/31/14 New Mexico Center for the Spatiotemporal Modeling of Cell Signaling This grant established the tenth NIGMS National Center for Systems Biology. Oliver was the Founding PI; leadership transitioned in January 2013 to B. Wilson who will lead the competing renewal. Oliver is now co-PI. The Center’s overall goal is to integrate quantitative biochemical measurement, novel imaging technologies and computational modeling to better understand membrane microdomain organization and the role of membrane protein mobility in the regulation of complex signaling pathways in immune and cancer cells. NIH R25CA153825 (Oliver, Datye) 9/1/10-8/31/15 Integrative Cancer Nanoscience and Microsystems (IC-NSMS) Training Center This multi-PI plan grant is for support of interdisciplinary graduate student and postdoc training in nanotechnology with applications to cancer. PHS 398/2590 (Rev. 11/07) Page Biographical Sketch Format Page